---
type: "Symbol"
title: "Keyuan Pharma (301281.SZ) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/301281.SZ/topics.md"
symbol: "301281.SZ"
parent: "https://longbridge.com/en/quote/301281.SZ.md"
count: 3
datetime: "2026-03-15T21:02:52.013Z"
locales:
  - [en](https://longbridge.com/en/quote/301281.SZ/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301281.SZ/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301281.SZ/topics.md)
---

# Keyuan Pharma (301281.SZ) — Community Discussions

### [Growth Dialogue: The Path of 'Looking Inward' and 'Growing Outward' for Lino Pharmaceutical](https://longbridge.com/en/topics/36666444.md)

- Author: [医药研究社](https://longbridge.com/en/profiles/15545088.md)
- Datetime: 2025-11-24T12:13:08.000Z
- Comments: 0
- In November, the picturesque city of Lishui was filled with the fragrance of medicine. The 19th Growth-Oriented Pharmaceutical Enterprises Development Conference (hereinafter referred to as the "G

### [Star Dialogue | From 'Manufacturing' to 'Intelligent' Medicine: How Does Linuo Pharmaceutical, a Subsidiary of Keyuan Pharmaceutical, Help Reshape the Future of the Industry?](https://longbridge.com/en/topics/31494626.md)

- Author: [医药研究社](https://longbridge.com/en/profiles/15545088.md)
- Datetime: 2025-07-04T12:47:10.000Z
- Comments: 0
- On July 1st, the annual pharmaceutical grand event with the theme "From Change to Innovation: Smartly Chaining the New Future of Pharmacies" kicked off. At the main venue of the Summer Star Co

### [[IPO Frontline] Wuhan Youji: The Dual Challenges of Performance Fluctuations and Capacity Expansion](https://longbridge.com/en/topics/21644837.md)

- Author: [财华社](https://longbridge.com/en/profiles/11651030.md)
- Datetime: 2024-06-06T02:59:29.000Z
- Comments: 0
- After three attempts to enter the Hong Kong stock market, Wuhan Youji, a leader in the toluene derivatives industry, has finally obtained the admission ticket from the Hong Kong Stock Exchange and suc

## References

- [Keyuan Pharma (301281.SZ)](https://longbridge.com/en/quote/301281.SZ.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301281.SZ/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301281.SZ/topics.md)